| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
bluedot [2022/05/12 01:13]
liam [Staff] | bluedot [2023/09/19 20:10] (current)
liam [COVID-19] |
|---|
| ==== The BIO.DIASPORA Project ==== | ==== The BIO.DIASPORA Project ==== |
| |
| DiaSpora produced a report in 2009 in collaboration with the [[Centre for Research on Inner City Health]] at [[St. Michael's Hospital]] titled "An Analysis of Canada’s Vulnerability to Emerging Infectious Disease Threats via the Global Airline Transportation Network".((//An Analysis of Canada’s Vulnerability to Emerging Infectious Disease Threats via the Global Airline Transportation Network.// (2009). The Centre for Research on Inner City Health; St. Michael’s Hospital. https://paulojraposo.github.io/assets/biodiasporareport2009_lowres.pdf)) In addition to [[Kamran Khan]], the team included [[Julien Arino]] of [[York University]] and the [[University of Manitoba]]; [[Felipe Calderon]], [[Angie Chan]], [[Jennifer Sears]], [[Paulo Raposo]], [[Wei Hu]] and [[Christine Heidebrecht]] of the [[Li Ka Shing Knowledge Institute]]; Dr. [[Michael Gardam]] of the [[Ontario Agency for Health Protection and Promotion]], [[University Health Network]] and the [[Dalla Lana School of Public Health]] at the [[University of Toronto]]; [[David Andrew Janes]] of the [[University of Waterloo]]; [[Michael MacDonald]] of [[Ryerson University]]; and [[Susan Wang]] of [[Queen's University]]. Funding was provided by the [[public_health_agencies:Public Health Agency of Canada]] (PHAC). The report shows the same interest in the 2003 [[SARS]] outbreak as its lead author, Khan. | DiaSpora produced a report in 2009 in collaboration with the [[Centre for Research on Inner City Health]] at [[St. Michael's Hospital]] titled "An Analysis of Canada’s Vulnerability to Emerging Infectious Disease Threats via the Global Airline Transportation Network".((//An Analysis of Canada’s Vulnerability to Emerging Infectious Disease Threats via the Global Airline Transportation Network.// (2009). The Centre for Research on Inner City Health; St. Michael’s Hospital. https://paulojraposo.github.io/assets/biodiasporareport2009_lowres.pdf)) In addition to [[Kamran Khan]], the team included [[Julien Arino]] of [[York University]] and the [[University of Manitoba]]; [[Felipe Calderon]], [[Angie Chan]], [[Jennifer Sears]], [[Paulo Raposo]], [[Wei Hu]] and [[Christine Heidebrecht]] of the [[Li Ka Shing Knowledge Institute]]; Dr. [[Michael Gardam]] of the [[Ontario Agency for Health Protection and Promotion]], [[University Health Network]] and the [[Dalla Lana School of Public Health]] at the [[University of Toronto]]; [[David Andrew Janes]] of the [[University of Waterloo]]; [[Michael MacDonald]] of [[Ryerson University]]; and [[Susan Wang]] of [[Queen's University]]. Funding was provided by the [[Public Health Agency of Canada]] (PHAC). The report shows the same interest in the 2003 [[SARS]] outbreak as its lead author, Khan. |
| |
| By 2011, DiaSpora had helped countries anticipate and react to the spread of disease at mass gatherings such as the 2010 [[Olympic Games]] in Vancouver, Canada and the 2012 Games in London, England, the [[FIFA World Cup]], and the annual Hajj pilgrimage in [[Saudi Arabia]].((//Impact Report 2010/2011.// (2011). Centre for Research on Inner City Health; St. Michael’s Hospital. https://web.archive.org/web/20130721142723/http://www.stmichaelshospital.com:80/pdf/crich/crich-impact-report-2010-11.pdf)) | By 2011, DiaSpora had helped countries anticipate and react to the spread of disease at mass gatherings such as the 2010 [[Olympic Games]] in Vancouver, Canada and the 2012 Games in London, England, the [[FIFA World Cup]], and the annual Hajj pilgrimage in [[Saudi Arabia]].((//Impact Report 2010/2011.// (2011). Centre for Research on Inner City Health; St. Michael’s Hospital. https://web.archive.org/web/20130721142723/http://www.stmichaelshospital.com:80/pdf/crich/crich-impact-report-2010-11.pdf)) |
| According to BlueDot, the company was the first in the world to detect the outbreak of [[COVID-19]] in Wuhan, China. It sent an alert to its customers on December 31, 2019, and used data on airline tickets to correctly predict the virus' travel to Bangkok, Seoul, Taipei, and Tokyo.((Niiler, E. (2020, January 25). //An AI Epidemiologist Sent the First Warnings of the Wuhan Virus.// Wired. https://archive.ph/EAiP4)) This came nine days before the [[World Health Organization]] sent out their own public warning.((//The first company to identify the coronavirus outbreak – Bluedot.// (2020, June 23). Bayslope. https://archive.ph/Flrs4)) | According to BlueDot, the company was the first in the world to detect the outbreak of [[COVID-19]] in Wuhan, China. It sent an alert to its customers on December 31, 2019, and used data on airline tickets to correctly predict the virus' travel to Bangkok, Seoul, Taipei, and Tokyo.((Niiler, E. (2020, January 25). //An AI Epidemiologist Sent the First Warnings of the Wuhan Virus.// Wired. https://archive.ph/EAiP4)) This came nine days before the [[World Health Organization]] sent out their own public warning.((//The first company to identify the coronavirus outbreak – Bluedot.// (2020, June 23). Bayslope. https://archive.ph/Flrs4)) |
| |
| | In January 2020, a team led by [[Isaac Bogoch]] published a rapid communication titled //"Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel"// with the BlueDot team.((Bogoch, I. I., Watts, A., Thomas-Bachli, A., Huber, C., Kraemer, M. U. G., & Khan, K. (2020). //Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel.// Journal of Travel Medicine, 27(2). https://doi.org/10.1093/jtm/taaa008)) The paper was submitted to the [[Journal of Travel Medicine]] on January 8, 2020, revised January 9, and accepted January 10. |
| ===== Technology ===== | ===== Technology ===== |
| |
